FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2004283283> ?p ?o ?g. }

• W2004283283 endingPage "1449" @default.
• W2004283283 startingPage "1443" @default.
• W2004283283 abstract "To investigate serum levels of transforming growth factor-beta1 and interferon-gamma in active ulcerative colitis and to assess changes during treatment.We prospectively evaluated serum from 25 patients with untreated active ulcerative colitis and 19 healthy controls. Disease activity score (DAI), serum transforming growth factor-beta1 and interferon-gamma levels were measured at baseline and after 7 days of conventional treatment. Disease activity score and transforming growth factor-beta1 were also assessed at 42 days.Baseline transforming growth factor-beta1 levels were significantly higher in patients than in controls (P < 0.02). On the 7th day, transforming growth factor-beta1 levels increased only in patients who responded (P < 0. 01); variations in transforming growth factor-beta1 levels and disease activity score were inversely correlated (r=- 0.72, P < 0. 001). At day 42, serum transforming growth factor-beta1 decreased significantly compared with the 7th day (P < 0.05). While in controls, interferon-gamma was undetectable; untreated patients had higher, widely variable, levels. At day 7, responders had higher interferon-gamma values than unresponsive cases. Variations in interferon-gamma correlated moderately with changes in transforming growth factor-beta1 (r=0.53, P < 0.05). Cytokine response did not depend upon the type of treatment.Both transforming growth factor-beta1 and interferon-gamma may play a role in the injury-repair process in active ulcerative colitis. Variations in circulating transforming growth factor-beta1 levels in the first week of treatment seem to be related to the therapeutic response." @default.
• W2004283283 created "2016-06-24" @default.
• W2004283283 creator A5002148840 @default.
• W2004283283 creator A5024191864 @default.
• W2004283283 creator A5025539556 @default.
• W2004283283 creator A5035738297 @default.
• W2004283283 creator A5035774916 @default.
• W2004283283 creator A5048961835 @default.
• W2004283283 creator A5054460165 @default.
• W2004283283 creator A5059596258 @default.
• W2004283283 creator A5065307055 @default.
• W2004283283 creator A5082394350 @default.
• W2004283283 creator A5088550835 @default.
• W2004283283 date "2000-11-27" @default.
• W2004283283 modified "2023-10-16" @default.
• W2004283283 title "Serum transforming growth factor-β1 levels increase in response to successful anti-inflammatory therapy in ulcerative colitis" @default.
• W2004283283 cites W1833914727 @default.
• W2004283283 cites W194825946 @default.
• W2004283283 cites W1976195770 @default.
• W2004283283 cites W1983819140 @default.
• W2004283283 cites W1989210966 @default.
• W2004283283 cites W1992650609 @default.
• W2004283283 cites W2011496352 @default.
• W2004283283 cites W2015326179 @default.
• W2004283283 cites W2044069347 @default.
• W2004283283 cites W2059068954 @default.
• W2004283283 cites W2074542308 @default.
• W2004283283 cites W2079517510 @default.
• W2004283283 cites W2082656085 @default.
• W2004283283 cites W2115601920 @default.
• W2004283283 cites W2118202213 @default.
• W2004283283 cites W2121650731 @default.
• W2004283283 cites W2125985655 @default.
• W2004283283 cites W2129379081 @default.
• W2004283283 cites W2129764267 @default.
• W2004283283 cites W2140250761 @default.
• W2004283283 cites W2150605496 @default.
• W2004283283 cites W2160875559 @default.
• W2004283283 cites W2169429901 @default.
• W2004283283 cites W2321205867 @default.
• W2004283283 cites W3000793605 @default.
• W2004283283 cites W4231819326 @default.
• W2004283283 doi "https://doi.org/10.1046/j.1365-2036.2000.00861.x" @default.
• W2004283283 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11069315" @default.
• W2004283283 hasPublicationYear "2000" @default.
• W2004283283 type Work @default.
• W2004283283 sameAs 2004283283 @default.
• W2004283283 citedByCount "19" @default.
• W2004283283 countsByYear W20042832832015 @default.
• W2004283283 countsByYear W20042832832016 @default.
• W2004283283 countsByYear W20042832832017 @default.
• W2004283283 countsByYear W20042832832018 @default.
• W2004283283 countsByYear W20042832832019 @default.
• W2004283283 countsByYear W20042832832020 @default.
• W2004283283 countsByYear W20042832832022 @default.
• W2004283283 countsByYear W20042832832023 @default.
• W2004283283 crossrefType "journal-article" @default.
• W2004283283 hasAuthorship W2004283283A5002148840 @default.
• W2004283283 hasAuthorship W2004283283A5024191864 @default.
• W2004283283 hasAuthorship W2004283283A5025539556 @default.
• W2004283283 hasAuthorship W2004283283A5035738297 @default.
• W2004283283 hasAuthorship W2004283283A5035774916 @default.
• W2004283283 hasAuthorship W2004283283A5048961835 @default.
• W2004283283 hasAuthorship W2004283283A5054460165 @default.
• W2004283283 hasAuthorship W2004283283A5059596258 @default.
• W2004283283 hasAuthorship W2004283283A5065307055 @default.
• W2004283283 hasAuthorship W2004283283A5082394350 @default.
• W2004283283 hasAuthorship W2004283283A5088550835 @default.
• W2004283283 hasBestOaLocation W20042832831 @default.
• W2004283283 hasConcept C118131993 @default.
• W2004283283 hasConcept C126322002 @default.
• W2004283283 hasConcept C134018914 @default.
• W2004283283 hasConcept C170493617 @default.
• W2004283283 hasConcept C203014093 @default.
• W2004283283 hasConcept C2775960820 @default.
• W2004283283 hasConcept C2776178377 @default.
• W2004283283 hasConcept C2778690821 @default.
• W2004283283 hasConcept C2779134260 @default.
• W2004283283 hasConcept C2780479503 @default.
• W2004283283 hasConcept C2780841837 @default.
• W2004283283 hasConcept C71924100 @default.
• W2004283283 hasConcept C90924648 @default.
• W2004283283 hasConceptScore W2004283283C118131993 @default.
• W2004283283 hasConceptScore W2004283283C126322002 @default.
• W2004283283 hasConceptScore W2004283283C134018914 @default.
• W2004283283 hasConceptScore W2004283283C170493617 @default.
• W2004283283 hasConceptScore W2004283283C203014093 @default.
• W2004283283 hasConceptScore W2004283283C2775960820 @default.
• W2004283283 hasConceptScore W2004283283C2776178377 @default.
• W2004283283 hasConceptScore W2004283283C2778690821 @default.
• W2004283283 hasConceptScore W2004283283C2779134260 @default.
• W2004283283 hasConceptScore W2004283283C2780479503 @default.
• W2004283283 hasConceptScore W2004283283C2780841837 @default.
• W2004283283 hasConceptScore W2004283283C71924100 @default.
• W2004283283 hasConceptScore W2004283283C90924648 @default.
• W2004283283 hasIssue "11" @default.
• W2004283283 hasLocation W20042832831 @default.
• W2004283283 hasLocation W20042832832 @default.

• next